Key facts
- It has raised $36.9M; the latest was Later Stage VC ($25.0M) in Apr 2025.
- Notable investors include European Innovation Council, Invest-NL (Investment Company), Oost NL, Utrecht Holdings, Bender Analytical Holding — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for AMT Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for AMT Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AMT Medical
Developer of coronary bypass technology designed to reduce bypass complications and shorten patient recovery. The company's technology can be tested before opening the coronary artery and prevent leakages and complications, enabling physicians to perform traditional heart bypass procedures faster, safer, easier, and less invasively for the patient.
- Sector
- Healthcare
- HQ
- Ede, Netherlands
- Founded
- 2015
- Employees
- 35
- Website
- amt-medical.nl/
- Ownership
- Privately Held (backing)
AMT Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AMT Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AMT Medical in its N-PORT filings yet. We sweep new filings monthly.